EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence

Bruna Bravo iD, Priscila Correia iD, José Euzébio Gonçalves Junior iD, Beatriz Sant'Anna iD, Delphine Kerob iD

Dermatologic Therapy · 2022-12 · 35 (12)

DOI: 10.1111/dth.15903 ↗

At a glance

Übersichtsarbeit in Dermatologic Therapy, published online on 2022-10-21. Written by Bruna Bravo and 4 co-authors. Institution: Bravo's Clinic, Rio de Janeiro, Brazil. Major MEDLINE topics: Skin Aging, Dermal Fillers, Cosmeceuticals, Botulinum Toxins, Type A. Cited 173 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Cosmetic Active International, L'Oréal.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.

Subjects

MeSH terms (MEDLINE)

Skin AgingDermal FillersCosmeceuticalsBotulinum Toxins, Type ACosmetic TechniquesHumansAdultHyaluronic AcidRejuvenationRandomized Controlled Trials as Topic

Author keywords

cosmeceuticaldermatologyhyaluronic acidskintopical application

Substances

Hyaluronic AcidDermal FillersCosmeceuticalsBotulinum Toxins, Type A

Authors and institutions

  • Bravo's Clinic, Rio de Janeiro, Brazil.
  • Scientific Expertise, Cosmetic Active, L'Oréal Brasil, Rio de Janeiro, Brazil.
  • Cosmetic Active International, L'Oréal, Paris, France.

ORCID profiles: Bruna Bravo, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant'Anna, Delphine Kerob

Funding

  • Cosmetic Active International, L'Oréal

Cite

APA

Bravo, B., Correia, P., Gonçalves Junior, J. E., Sant'Anna, B., & Kerob, D. (2022). Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy, 35(12). https://doi.org/10.1111/dth.15903

Vancouver

Bravo B, Correia P, Gonçalves Junior JE, Sant'Anna B, Kerob D. Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy. 2022;35(12). doi:10.1111/dth.15903

BibTeX
@article{Bravo2022,
  author = {Bravo, Bruna and Correia, Priscila and Gonçalves Junior, José Euzébio and Sant'Anna, Beatriz and Kerob, Delphine},
  title = {Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence},
  journal = {Dermatologic Therapy},
  year = {2022},
  volume = {35},
  number = {12},
  doi = {10.1111/dth.15903}
}
Start for free →